Consumer Goods » Food, Beverages & Tobacco | TherapeuticsMD Inc.

TherapeuticsMD Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
28,419.30
54,217.20
85,077.00
89,875.50
76,925.40
132,617.20
Depreciation, Depletion & Amortization
58.10
52.50
62.40
132.50
213.10
293.90
Other Funds
5,670.40
5,224.90
7,211.90
19,935.90
6,893.50
9,147.80
Funds from Operations
22,690.70
48,939.80
77,802.80
69,807.10
69,818.70
123,175.40
Changes in Working Capital
1,922.70
3,418.80
1,241.40
664.70
6,336.90
16,363.60
Net Operating Cash Flow
20,768.10
45,521.00
79,044.10
69,142.30
76,155.60
106,811.80
Capital Expenditures
479.80
617.40
584.40
1,241.40
827.10
Net Investing Cash Flow
583.60
606.80
584.40
1,255.50
827.10
Issuance/Reduction of Debt, Net
4,691.80
-
-
-
-
Net Financing Cash Flow
73,989.40
43,298.10
92,973.20
137,225.50
72,584.20
Net Change in Cash
52,637.80
2,829.70
13,344.70
66,827.70
4,398.50
Free Cash Flow
20,808.90
45,552.00
79,209.40
69,538.50
76,217.40
Change in Capital Stock
78,681.30
43,298.10
92,973.20
137,225.50
72,584.20
Other Uses
103.70
10.70
-
14.00
-

About TherapeuticsMD

View Profile
Address
6800 Broken Sound Parkway NW
Boca Raton Florida 33487
United States
Employees -
Website http://www.therapeuticsmd.com
Updated 07/08/2019
TherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the vitaMedMD and BocaGreenMD brands.